Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

NCT01617681 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediatric Hypertension With or Without CKD

Interventions

DRUG: VAL489
DRUG: VAL489 matching placebo

Sponsor

Novartis Pharmaceuticals